Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Therapeutics MD(TXMD) the Revenue is 869 K (-8.72%);the EBIT is -280 K (+12.23%);the EPS is 0.0092 (-80.62%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B8.72%
----
----
EBIT
-0.00B12.23%
----
----
EPS
0.009280.62%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf